6-32394774-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001304561.2(BTNL2):c.1330G>A(p.Glu444Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001304561.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTNL2 | NM_001304561.2 | c.1330G>A | p.Glu444Lys | missense_variant | 6/8 | ENST00000454136.8 | NP_001291490.1 | |
TSBP1-AS1 | NR_136245.1 | n.303-10680C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BTNL2 | ENST00000454136.8 | c.1330G>A | p.Glu444Lys | missense_variant | 6/8 | 5 | NM_001304561.2 | ENSP00000390613 | P1 | |
TSBP1-AS1 | ENST00000645134.1 | n.627+4021C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250860Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135576
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1460832Hom.: 0 Cov.: 32 AF XY: 0.0000262 AC XY: 19AN XY: 726538
GnomAD4 genome AF: 0.000223 AC: 34AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 07, 2022 | The c.1330G>A (p.E444K) alteration is located in exon 6 (coding exon 6) of the BTNL2 gene. This alteration results from a G to A substitution at nucleotide position 1330, causing the glutamic acid (E) at amino acid position 444 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at